Powala Christopher 4
4 · Aclaris Therapeutics, Inc. · Filed Feb 5, 2019
Insider Transaction Report
Form 4
Powala Christopher
Chief Operating Officer
Transactions
- Tax Payment
Common Stock
2019-02-01$6.96/sh−1,114$7,753→ 141,729 total - Exercise/Conversion
Restricted Stock Units
2019-02-01−3,400→ 10,200 total→ Common Stock (3,400 underlying) - Exercise/Conversion
Common Stock
2019-02-01+3,400→ 142,843 total
Holdings
- 130,434(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units being reported in this Form 4.
- [F3]These shares are held by the Christopher V. Powala Aclaris Irrevocable Trust, for which Mr. Powala serves as trustee.
- [F4]The shares underlying these restricted stock units vest in four equal annual installments beginning on February 1, 2019, subject to the reporting person's continuous service with the issuer as of the applicable vesting date.